Complex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin

European Journal of Cell Biology
Michał MilewskiJerzy Bal

Abstract

Diverse subcellular localizations of the huntingtin-containing inclusion bodies are frequently suspected of reflecting crucial divisions between different cellular pathways contributing to the pathophysiology of Huntington's disease. Here, we use a panel of different N-terminal huntingtin fragments overexpressed in transfected neuronal and non-neuronal cells to demonstrate that it is the length of the N-terminal huntingtin fragments rather than a presence of any specific amino acid sequences that determines the ratio between the nuclear and cytoplasmic inclusion bodies. Importantly, the length of those fragments does also seem to strongly influence the folding of the aggregating huntingtin species, as indicated by the apparent differences in their accessibility for different antibodies directed against particular subdomains within the N-terminal part of huntingtin, although these differences do not correlate with the peptides' ability to efficiently aggregate within the cell nucleus. Furthermore, the relatively long huntingtin fragment containing 588 amino acids of the reference sequence shows intracellular behavior that is substantially different from that exhibited by its shorter counterparts (containing either 171, 120, 89 o...Continue Reading

References

Jun 12, 1998·The Journal of Cell Biology·A S HackamM R Hayden
Sep 10, 1999·Molecular and Cellular Neurosciences·M F PetersC A Ross
Jun 27, 2002·The Journal of Biological Chemistry·Michal I MilewskiGarry R Cutting
Oct 24, 2002·Human Molecular Genetics·Wen YangRonald Wetzel
Oct 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Eugenia TrushinaCynthia T McMurray
Aug 25, 2004·The International Journal of Biochemistry & Cell Biology·Noboru Mizushima
Aug 25, 2004·The International Journal of Biochemistry & Cell Biology·Isei TanidaEiki Kominami
Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Martin L DuennwaldSusan Lindquist
Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Martin L DuennwaldSusan Lindquist
Sep 16, 2006·Molecular Aspects of Medicine·Brinda Ravikumar, David C Rubinsztein
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Marie W WootenMichael C Wooten
Jul 1, 2008·The European Journal of Neuroscience·Joana M Gil, Ana Cristina Rego
Jun 6, 2009·The Journal of Biological Chemistry·Justin LegleiterPaul J Muchowski
Jun 3, 2010·Cell Biology International·Daniel Bak, Michał Milewski
Jan 24, 2013·Current Topics in Medicinal Chemistry·Danny M Hatters
Mar 19, 2014·Drug Discovery Today·Constanza J Cortes, Albert R La Spada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.